Form 10-Q ARROWHEAD PHARMACEUTICAL For: Jun 30
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Needham Starts NeoVolta (NEOV) at Buy
- Spain's ex-transport minister sentenced to 24 years for corruption
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
Arrowhead Research (ARWR) PT Raised to $18 at Cantor Fitzgerald
August 8, 2018 6:58 AM EDTCantor Fitzgerald raised its price target on Arrowhead Research (NASDAQ: ARWR) to $18.00 (from $13.00) while maintaining a Overweight rating following 3Q18 financial and corporate updates.
Analyst Elemer Piros commented, "The company hosted a call and highlighted upcoming data presentations at AASLD (pending abstract... More
